₁₀Ken Takeuchi

Summary for 2004 [at-glance overview of Ken Takeuchi work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author Ken Takeuchi. According to available data, in 2004 Ken Takeuchi published at least 10 articles. This work was completed in collaboration with several authors including Hanai, Hiroyuki and Iida, Takayuki. Many other authors have collaborated with Ken Takeuchi as well. There is no information about the funding or the grants awarded to support this work.

Ken Takeuchi has rank 15 when compared to all other authors using the keyword Colitis, Ulcerative. Analysis of the article abstracts and the titles suggests that Ken Takeuchi professional interests are focused around "patients connective tissue", "connective tissue diseases" and "patients ulcerative colitis". These might also be referred to as "ulcerative colitis", "autoimmune response" or "intestinal permeability". Statistical analysis shows that Ken Takeuchi's writing is likely to contains terms "patients", "complex", "intestinal", "ulcerative", "disease" and "colitis".

Unfortunately, there is not enough information to establish Ken Takeuchi affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for Ken Takeuchi]

Do you know Ken Takeuchi who matches the profile above? Click the photo and let us know!

Alternative names (1) [other authors with names similar to Ken Takeuchi]

₃₆₁Takeuchi, K

Year 2004 Charts [Ken Takeuchi frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of Ken Takeuchi publication and funding history for the range of years]

Emails (5) [email addresses extracted from Ken Takeuchi affiliations]

hidden to prevent spam, click here to reveal

Ken Takeuchi Coauthors (38) [all coauthors with the number of joint publications]

5

4

3

3

2

2

2

2

2

2

2

₄Matsushita, Masakazu

2

2

2

2

1

1

₁₆Fujiyama, Yoshihide

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (7) [condensed summary of the Ken Takeuchi affiliations, the leading number and the color conveys importance]

₂Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan.
₂Department of Medicine, Hamamatsu University, Hamamatsu, Japan.
₁Department of Endoscopic and Photodynamic Medicine, Hamamatsu University, 1-20-1, Handayama, Hamamatsu 431-3192, Japan.
₁Department of Gastroenterology, Guy's School of Medicine, London SE5 9PJ, UK.
₁Department of Pharmacy, University of Tokyo Hospital, Faculty of Medicine, Tokyo, Japan.
₁Department of Endoscopic and Photodynamic Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
₁Department of Medicine, Guy's, King's, St Thomas' School of Medicine, Bessemer Road, London SE5 9PJ, UK.

Key Opinion Leader In [Ken Takeuchi is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₁₅Colitis, Ulcerative

Keywords (32) [keywords assigned to Ken Takeuchi articles by PubMed, the leading number and the color conveys importance]

₁₀Humans | ₆Female | ₆Male | ₅Colitis, Ulcerative | ₅Adult | ₅Middle Aged | ₃Adolescent | ₂Lupus Erythematosus, Systemic | ₂Leukapheresis | ₂Severity of Illness Index | ₂Monocytes | ₂Neutrophil Activation | ₂Neutrophils | ₁Intestines | ₁C-Reactive Protein | ₁Phytotherapy | ₁Multiprotein Complexes | ₁Chromatography, Affinity | ₁Sensitivity and Specificity | ₁Family Health | ₁Genotype | ₁Blood Component Removal | ₁Chemotherapy, Adjuvant | ₁Immunotherapy | ₁Muscle Proteins | ₁Feces | ₁Permeability | ₁Recombinant Proteins | ₁Proteasome Endopeptidase Complex | ₁Mesalamine | ₁Cohort Studies | ₁Chromatography, High Pressure Liquid

Ken Takeuchi Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; Ken Takeuchi might be a good expert witness on these terms]

₃₀patients | ₁₆complex | ₁₂intestinal | ₁₁ulcerative | ₁₁disease | ₁₀colitis | ₁₀response | ₉pcna | ₉autoimmune | ₈serum | ₈patient | ₇increased | ₇permeability | ₇treatment | ₇gbf | ₆apheresis | ₆monocyte | ₆granulocyte | ₆significantly | ₆remission | ₆cell | ₆inflammation | ₆sle | ₆activity | ₆may | ₆antibodies | ₅chemotherapy | ₅uc | ₅induction | ₅sera | ₅refractory | ₅control
₉ulcerative colitis | ₉autoimmune response | ₆intestinal permeability | ₆pcna complex | ₅patients connective | ₅tissue diseases | ₅connective tissue | ₄patients ulcerative | ₄granulocyte monocyte | ₄intestinal inflammation | ₄monocyte apheresis | ₄sensitivity-based induction | ₄s-ri rii | ₄lung cancer | ₃side effects | ₃increased intestinal | ₃nuclear antigen | ₃moderately severe | ₃refractory ulcerative | ₃peripheral blood | ₃cell nuclear | ₃disease activity | ₃proliferating cell | ₃control group | ₃lupus erythematosus | ₃patients active | ₃stage iiia | ₃gbf group | ₃remission patients | ₂28alpha patients | ₂induction chemotherapy--report | ₂red blood
₅patients connective tissue | ₅connective tissue diseases | ₄patients ulcerative colitis | ₃increased intestinal permeability | ₃cell nuclear antigen | ₃proliferating cell nuclear | ₂monocyte apheresis refractory | ₂granulocyte monocyte apheresis | ₂activator 28alpha patients | ₂adsorptive granulocyte monocyte | ₂induction chemotherapy--report case | ₂multiprotein complexes patients | ₂lung cancer using | ₂refractory ulcerative proctitis | ₂monocyte apheresis versus | ₂remission patients ulcerative | ₂using sensitivity-based induction | ₂levels disease activity | ₂complexes patients connective | ₂response proteins proliferating | ₂response proteasome activator | ₂activity patients ulcerative | ₂autoimmune response proteins | ₂proteasome activator 28alpha | ₂germinated barley foodstuff | ₂intestinal permeability inflammatory | ₂disease activity patients | ₂healthy japanese population | ₂red blood cells | ₂receptors ii levels | ₂nuclear antigen multiprotein | ₂soluble tnf-alpha receptors

Reader's Comments (0) [comments posted by readers of Ken Takeuchi profile]